Collectively, these finding indicate that down-regulated annexin V predicts a poor prognosis and is closely correlated with tumor angiogenesis, suggesting that Annexin V can be used as a novel angiogenesis inhibitor in tumor therapy. The gene discussed is ANXA5; the disease is neoplasm.